Coronavirus

Summaries

AdobeStock_393558874

NICE COVID-19 management

2021-10-06T08:00:00+01:00By

Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings

AdobeStock_340703775

UKHSA management of staff exposure to COVID-19

2021-09-01T10:25:00+01:00By UK Health Security Agency

This summary provides guidance on the management of staff according to COVID-19 exposures, symptoms, and test results

AdobeStock_335029203

UKHSA COVID-19 infection prevention and control guidance

2021-08-20T10:30:00+01:00By UK Health Security Agency

Summary of the latest UK guidance on infection prevention and control measures for COVID-19

Syringe with vaccine_AS resized

PHE COVID-19 vaccination guidance

2021-08-12T08:30:00+01:00By

A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme

AdobeStock_384168494

COVID-19 rapid guideline on VITT

2021-08-10T14:19:00+01:00By

This Guidelines summary covers vaccine-induced immune thrombocytopenia and thrombosis, a syndrome that has been reported in rare cases after COVID-19 vaccination

injection

PHE maintaining immunisation programmes during COVID-19

2021-06-11T11:16:00+01:00By PHE and NHS England

A brief summary providing the key points for primary care on maintaining immunisation programmes during the COVID-19 pandemic

Pregnant woman and doctor AS (thumbnail)

PHE inadvertent vaccination in pregnancy guideline

2021-06-07T09:19:00+01:00By

This concise and useful summary covers monitoring of women vaccinated in pregnancy or shortly before conception

AdobeStock_292279272

COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response

2021-04-13T13:57:00+01:00By

A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic

AdobeStock_287082164

COVID-19 rapid guideline on dermatological conditions

2021-04-13T13:49:00+01:00By

The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic

AdobeStock_162937550

COVID-19 guideline on rheumatological autoimmune, inflammatory, and metabolic bone disorders

2021-04-09T15:27:00+01:00By

This guideline aims to maximise the safety of children and adults with rheumatological autoimmune, inflammatory, and metabolic bone disorders during the COVID-19 pandemic

covid doctor

UKHSA SARS-CoV-2 reinfection guideline

2021-03-23T14:49:00+00:00By UK Health Security Agency

A concise summary of guidance on when to suspect SARS-CoV-2 reinfection and how to investigate and manage it in primary care

AdobeStock_407210206

WHO COVID-19 clinical management guideline

2021-02-19T13:20:00+00:00By World Health Organization

An easy-to-digest summary of World Health Organization guidance for clinicians involved in the care of patients with suspected or confirmed COVID-19

AdobeStock_319718852

COVID-19 rapid guideline on systemic anticancer treatments

2021-02-18T11:53:00+00:00By

This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection

AdobeStock_133646819

HEART UK Managing hyperlipidaemia and COVID-19

2021-02-17T14:44:00+00:00By HEART UK

A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19

AdobeStock_329035023

NICE ‘long COVID’ guideline

2020-12-18T13:56:00+00:00By , , Royal College of General Practitioners

Recommendations for identifying and managing ‘long-COVID’ in primary care

Nurse writing notes_AS resized

NHS England COVID-19 guidance for community pharmacy

2020-10-30T08:30:00+00:00By NHS England and NHS Improvement

This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation

AdobeStock_90128408

Pharmacy Quality Scheme (PQS) 2020/2021 part 2

2020-10-29T13:40:00+00:00By NHS Business Services Authority

This summary of the Pharmacy Quality Scheme (PQS) 2020/21 is intended as an aide-memoir or checklist for community pharmacists and must be viewed in conjuction with the full guidance which gives detailed instructions on what must be completed and submitted

AdobeStock_217828923

Pharmacy Quality Scheme (PQS) 2020/2021 part 1

2020-10-29T13:38:00+00:00By NHS Business Services Authority

This summary of the Pharmacy Quality Scheme (PQS) 2020/21 is intended as an aide-memoir or checklist for community pharmacists and must be viewed in conjuction with the full guidance which gives detailed instructions on what must be completed and submitted.

diabetic covid

NHS guideline for delivering diabetes care during COVID-19

2020-10-26T00:00:00+00:00By NHS England and NHS Improvement/Dr Chirag Bakhai

This NHS guidance for general practice covers the key points of delivering diabetes care during the challenging times of the COVID-19 pandemic

Coronavirus visualisation

COVID-19 rapid guideline on dialysis

2020-09-14T09:10:00+01:00By

This Guidelines summary covers the provision of care for patients requiring dialysis in the context of the COVID-19 outbreak

doctor and female patient video consultation

NHS video consulting guideline

2020-09-03T16:52:00+01:00By NHS England

This Guidelines summary covers guidance for safe video consulting in general practice during the COVID-19 pandemic

AdobeStock_347005261

COVID-19 rapid guideline on immunocompromised children

2020-08-25T04:17:00+01:00By

This summary aims to maximise the safety of children and young people who are immunocompromised during the COVID-19 pandemic

contraceptive pills

PCWHF HRT provision during COVID-19 guidance

2020-07-03T11:40:00+01:00By

This summary is intended to aid primary healthcare practitioners in initiating, reviewing, and prescribing hormone replacement therapy for women during COVID-19.

Pills + magnifying glass

NHS guidance on NSAIDs in COVID-19

2020-06-26T12:57:00+01:00By NHS England

This summary sets out the clinical policy for the acute use of non-steroidal anti-inflammatory drugs (NSAIDs) in people with or at risk of COVID-19.

Human kidneys blue with red highlights abstract

COVID-19 rapid guideline: chronic kidney disease

2020-05-20T12:36:00+01:00By

This COVID-19 rapid guideline aims to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.

AdobeStock_332747243

COVID-19 rapid guideline on COPD

2020-04-17T17:02:00+01:00By

The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.

AdobeStock_289304487

COVID-19 rapid guideline on severe asthma

2020-04-17T13:39:00+01:00By

The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.

AdobeStock_332278723

COVID-19: video consultations—information for general practices

2020-04-07T15:14:00+01:00By

COVID-19 creates an unprecedented situation. Many GP practices are considering introducing video consultations as a matter of urgency to reduce risk of contagion.